Matthew G. Jones focuses his practice on mergers and acquisitions, corporate governance and general corporate matters. He also has significant experience advising corporate clients and investment banks across a variety of financing transactions.
Jones’s corporate clients have included Booking Holdings, Brightline, British American Tobacco, Brunswick, Cable One, Conduent, Cox Communications, Crown Castle, DHT, Eurazeo, FactSet, Fortress Transportation & Infrastructure Investors, Frontier Communications, Johnson & Johnson, Kenvue, Martin Marietta, New Fortress Energy, New Media, Roivant Sciences, Stanley Black & Decker, Toll Brothers, Viatris and ZimVie.
Lawdragon Honors
| Honor | Year | Practice |
|---|---|---|
| The 2026 Lawdragon 500 Leading Dealmakers in America | 2026 | M&A, Corporate Governance |
| The 2025 Lawdragon 500 Leading Dealmakers in America | 2025 | M&A, Corporate Governance |
| The 2025 Lawdragon 500 X – The Next Generation | 2025 | Securities, Finance |
| The 2024 Lawdragon 500 X – The Next Generation | 2024 | Securities, Finance |
| Lawdragon 500 X – The Next Generation | 2023 | Securities, Finance |
Jones’s notable transactions include representing:
- Frontier Communications in its pending $20 billion acquisition by Verizon and its $1.352 billion sale of operations in Idaho, Montana, Oregon and Washington to WaveDivision Capital in partnership with Searchlight;
- Rock-Tenn in its $16 billion combination with MeadWestvaco;
-
Cano Health shareholders, including members of management, in the $4.4 billion SPAC merger with Jaws Acquisition Corp., including an $800 million PIPE investment;
-
Johnson & Johnson in its $3.4 billion acquisition of Auris Health and the $2.8 billion sale of its Advanced Sterilization Products business to Fortive;
- Martin Marietta in its $2.05 billion acquisition of aggregates operations from Blue Water Industries, its acquisition of Premier Magnesia and its pending exchange of certain assets with Quikrete;
-
New Media in its $1.4 billion acquisition of Gannett;
-
ZimVie in its $730 million acquisition by ARCHIMED and the $375 million sale of its spine business to H.I.G. Capital;
-
Brunswick in the $490 million sale of its Fitness business to KPS;
-
Brightline in its acquisition of XpressWest;
-
Conduent in the sale of its U.S.‑based human resource consulting and actuarial business to H.I.G. Capital;
-
Eurazeo in its majority investment in WorldStrides;
-
Fortress in Nationstar Mortgage’s merger with WMIH; and
-
Roivant Sciences in its Strategic Alliance with Sumitomo Dainippon Pharma.